chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 56.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Nausea, Pyrexia
Clinical narrative: diarrhea; I still don't feel quite well; i felt almost like a mild fever; light headed; little nauseated; quite chilled; had nausea that worsened when lying down and felt like i was drunk (balance/coordination, clarity of thought); had nausea that worsened when lying down and felt like i was drunk (balance/coordination, clarity of thought); This is a spontaneous report from a contactable consumer (patient). This 56-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE) (lot number EL3246/expiration date: unknown), via unknown route of administration, on 19Jan2021 03:30 PM (at the age of 56 years old) as a single dose on left arm for COVID-19 immunisation for COVID-19 immunisation at a hospital. Relevant medical history included hypothyroid, hypertension, celiac, chronic dermatitis. The patient allergic to statins, gluten-intolerant (celiac). The patient was not pregnant at time of vaccination. Relevant concomitant medications included Levothyroxine, Irbesartin, Vitamins. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. It was reported that on 19Jan2021 10:30 PM, about 7 hours after the shot and for the next 12 hours, she was quite chilled, had nausea that worsened when lying down and felt like she was drunk (balance/coordination, clarity of thought). After 12 hours of those symptoms, the drunk feeling and nausea were gone but she has since then struggled with diarrhea if she eats anything not completely bland, including today (4 days later). She stated "I still don't feel quite well and if I am very active (like she was packing boxes last night), I felt almost like a mild fever, light headed and a little nauseated." The outcome of the events chills, nausea, feeling drunk was recovered after 12 hrs later. The outcome of events diarrhea, don't feel quite well, fever, light headed and nauseated was not recovered. No treatment was received for the events. Since the vaccination, the patient has not been tested for COVID-19.
Age: 37.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Blood pressure measurement, Heart rate, Oxygen saturation, Sinus tachycardia, Throat irritation
Clinical narrative: Within minute of injection began to have numbness at back of throat and tongue; Within minute of injection began to have numbness at back of throat and tongue; This is a spontaneous report from a contactable nurse (patient). A 37-year-old non-pregnant female patient received her second dose of bnt162b2 (BNT162B2 reported as PFIZER COVID-19 VACCINE; lot number: EL1287; expiration date: unknown), via an unspecified route of administration left arm on 20Jan2021 14:45 at a single dose for covid-19 immunization. The patient medical history was not reported. The patient has no known allergies before vaccination. The patient was not diagnosed with COVID prior vaccination. Concomitant medication included duloxetine hydrochloride (CYMBALTA) and cetirizine hydrochloride (ZYRTEC). The patient did not have other vaccine in four weeks. The patient received her first dose of bnt162b2 (BNT162B2 reported as PFIZER COVID-19 VACCINE; lot number: EH9899) at the age of 37-year-old via an unspecified route of administration left arm on 28Dec2021 11:00 AM at a single dose for covid-19 immunization. The patient received her vaccine Public Health Clinic/Veterans Administration facility. The patient reported that within minute (20Jan2021 02:45 PM) of injection, began to have numbness at back of throat and tongue. No swelling or difficulty breathing was experienced by the patient. The patient received treatment for the adverse events which included diphenhydramine 50mg IM. The patient did not have COVID tested post vaccination. The adverse event required a doctor or other healthcare professional office/clinic visit. The outcome of the events was recovered in Jan2021.
Age: 37.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Hypoaesthesia oral, Pharyngeal hypoaesthesia
Clinical narrative: Within minute of injection began to have numbness at back of throat and tongue; Within minute of injection began to have numbness at back of throat and tongue; This is a spontaneous report from a contactable nurse (patient). A 37-year-old non-pregnant female patient received her second dose of bnt162b2 (BNT162B2 reported as PFIZER COVID-19 VACCINE; lot number: EL1287; expiration date: unknown), via an unspecified route of administration left arm on 20Jan2021 14:45 at a single dose for covid-19 immunization. The patient medical history was not reported. The patient has no known allergies before vaccination. The patient was not diagnosed with COVID prior vaccination. Concomitant medication included duloxetine hydrochloride (CYMBALTA) and cetirizine hydrochloride (ZYRTEC). The patient did not have other vaccine in four weeks. The patient received her first dose of bnt162b2 (BNT162B2 reported as PFIZER COVID-19 VACCINE; lot number: EH9899) at the age of 37-year-old via an unspecified route of administration left arm on 28Dec2021 11:00 AM at a single dose for covid-19 immunization. The patient received her vaccine Public Health Clinic/Veterans Administration facility. The patient reported that within minute (20Jan2021 02:45 PM) of injection, began to have numbness at back of throat and tongue. No swelling or difficulty breathing was experienced by the patient. The patient received treatment for the adverse events which included diphenhydramine 50mg IM. The patient did not have COVID tested post vaccination. The adverse event required a doctor or other healthcare professional office/clinic visit. The outcome of the events was recovered in Jan2021.
Age: 40.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Lymphadenopathy
Clinical narrative: Swelling of lymph nodes in her armpit on the same side; This is a spontaneous report from a contactable consumer (patient). This 40-year-old female patient received her second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE) via an unspecified route of administration on 20Jan2021 (at the age of 40-years-old) as a single dose in the left arm for COVID-19 immunization. Medical history was not provided. Concomitant medications were not reported. The patient previously received dose 1 of BNT162B2 (lot number EL1284) on 30Dec2020 for COVID-19 immunization.The patient reported swelling of lymph nodes in her armpit on the same side that she received BNT162B2 which she noticed yesterday around noon (as of 22Jan2020). She wanted to report, further asking if it was common and how long it would last. She noted that this event was not seen with the first dose and was unsure if this was normal or not. The patient took ibuprofen for treatment. The clinical outcome of swelling of lymph nodes in her armpit on the same side was reported as not recovered.  The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.
Age: 50.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pruritus, Throat irritation, Urticaria
Clinical narrative: After receiving the COVID-19 vaccination the patient experienced the following adverse events during the 15 minute observation period post-vaccine administration:  rash/urticaria, itching and difficulty breathing.  Patient at 15 min post injection complained of throat fullness, itching, flushing, rash to chest area.   Vital signs stable with Pulse ox at 100%.  Rapid response called.  Patient taken to ED for more in depth evaluation.  Patient received epinephrine IM, methylprednisolone, famotidine, diphenhydramine.  Patient had slight recurrence of some throat itching approximately 3 hours post arrival to ER.  Given oral diphenhydramine & symptoms resolved.  After 4 hours of observation there was no recurrent anaphylaxis.  Patient was discharged with prescriptions for EpiPen & oral prednisone.
Age: 50.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dyspnoea, Flushing, Physical examination, Pruritus, Rash
Clinical narrative: After receiving the COVID-19 vaccination the patient experienced the following adverse events during the 15 minute observation period post-vaccine administration:  rash/urticaria, itching and difficulty breathing.  Patient at 15 min post injection complained of throat fullness, itching, flushing, rash to chest area.   Vital signs stable with Pulse ox at 100%.  Rapid response called.  Patient taken to ED for more in depth evaluation.  Patient received epinephrine IM, methylprednisolone, famotidine, diphenhydramine.  Patient had slight recurrence of some throat itching approximately 3 hours post arrival to ER.  Given oral diphenhydramine & symptoms resolved.  After 4 hours of observation there was no recurrent anaphylaxis.  Patient was discharged with prescriptions for EpiPen & oral prednisone.
Age: 50.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Sensation of foreign body, Urticaria
Clinical narrative: After receiving the COVID-19 vaccination the patient experienced the following adverse events during the 15 minute observation period post-vaccine administration:  rash/urticaria, itching and difficulty breathing.  Patient at 15 min post injection complained of throat fullness, itching, flushing, rash to chest area.   Vital signs stable with Pulse ox at 100%.  Rapid response called.  Patient taken to ED for more in depth evaluation.  Patient received epinephrine IM, methylprednisolone, famotidine, diphenhydramine.  Patient had slight recurrence of some throat itching approximately 3 hours post arrival to ER.  Given oral diphenhydramine & symptoms resolved.  After 4 hours of observation there was no recurrent anaphylaxis.  Patient was discharged with prescriptions for EpiPen & oral prednisone.
Age: 31.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Dizziness, Dyspnoea
Clinical narrative: Still getting heat rashes; Had an anaphylactic reaction; Feels tired all day; This is a spontaneous report from a contactable consumer (patient). A 31-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL3302), via an unspecified route of administration in arm left on 22Jan2021 09:30 at single dose for COVID-19 immunisation. Medical history included Hashimoto's disease. The patient's concomitant medications were not reported. The patient previously took HPV VACCINE VLP RL1 4V (YEAST) (GARDASIL, number of previous doses: 3), and clindamycin and experienced allergic to clindamycin. The patient experienced an anaphylactic reaction on 22Jan2021 09:45 requiring treatment with an Epipen and transportation to the hospital, heat rashes up until last night 24Jan2021, and felt tired all day in Jan2021. Patient was "worried about how much benadryl" she had been taking. Patient went to the emergency room (ER), received some treatment and was released after 5 hours. She was not fully recovered. She was still experiencing rashes and felt tired all day. Treatment received for events anaphylactic reaction and heat rashes. The patient underwent lab tests and procedures which included blood work: normal on 22Jan2021, and white cell count: slightly increased on 22Jan2021. Outcome of event anaphylactic reaction was resolving, and of other events was not resolved.
Age: 31.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Anaphylactic reaction, Blood test normal, Fatigue, Miliaria, White blood cell count increased
Clinical narrative: Still getting heat rashes; Had an anaphylactic reaction; Feels tired all day; This is a spontaneous report from a contactable consumer (patient). A 31-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL3302), via an unspecified route of administration in arm left on 22Jan2021 09:30 at single dose for COVID-19 immunisation. Medical history included Hashimoto's disease. The patient's concomitant medications were not reported. The patient previously took HPV VACCINE VLP RL1 4V (YEAST) (GARDASIL, number of previous doses: 3), and clindamycin and experienced allergic to clindamycin. The patient experienced an anaphylactic reaction on 22Jan2021 09:45 requiring treatment with an Epipen and transportation to the hospital, heat rashes up until last night 24Jan2021, and felt tired all day in Jan2021. Patient was "worried about how much benadryl" she had been taking. Patient went to the emergency room (ER), received some treatment and was released after 5 hours. She was not fully recovered. She was still experiencing rashes and felt tired all day. Treatment received for events anaphylactic reaction and heat rashes. The patient underwent lab tests and procedures which included blood work: normal on 22Jan2021, and white cell count: slightly increased on 22Jan2021. Outcome of event anaphylactic reaction was resolving, and of other events was not resolved.
Age: 31.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Anaphylactic reaction, Laboratory test normal, Skin warm
Clinical narrative: Still getting heat rashes; Had an anaphylactic reaction; Feels tired all day; This is a spontaneous report from a contactable consumer (patient). A 31-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL3302), via an unspecified route of administration in arm left on 22Jan2021 09:30 at single dose for COVID-19 immunisation. Medical history included Hashimoto's disease. The patient's concomitant medications were not reported. The patient previously took HPV VACCINE VLP RL1 4V (YEAST) (GARDASIL, number of previous doses: 3), and clindamycin and experienced allergic to clindamycin. The patient experienced an anaphylactic reaction on 22Jan2021 09:45 requiring treatment with an Epipen and transportation to the hospital, heat rashes up until last night 24Jan2021, and felt tired all day in Jan2021. Patient was "worried about how much benadryl" she had been taking. Patient went to the emergency room (ER), received some treatment and was released after 5 hours. She was not fully recovered. She was still experiencing rashes and felt tired all day. Treatment received for events anaphylactic reaction and heat rashes. The patient underwent lab tests and procedures which included blood work: normal on 22Jan2021, and white cell count: slightly increased on 22Jan2021. Outcome of event anaphylactic reaction was resolving, and of other events was not resolved.
Age: 31.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Dizziness, Dyspnoea
Clinical narrative: My skin is heating up a lot; This is a spontaneous report from a contactable consumer.  A 31-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) lot number EL3302 via an unspecified route of administration on 22Jan2021 at SINGLE DOSE for covid-19 immunisation.  Medical history included Hashimoto's disease. Concomitant medication included levothyroxine (LEVOTHYROXINE). Ten minutes after vaccination the patient reported anaphylactic reaction to it "my skin is heating up a lot" and was hospitalized on the same day 22Jan2021. the consumer was discharged same day 6 hours later. The patient underwent lab tests and procedures which included investigation: everything was normal. The action taken was not applicable. Therapeutic measures included "Benadryl, and they gave me Epipen and then I am taking Benadryl.  The patient just wanted to knowhow many days or how long does it take for the first vaccine to be out of your system, or how long will I be getting these reactions. Patient worked in a retirement facility. Event outcome is unknown.
Age: 31.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Anaphylactic reaction, Blood test normal, Fatigue, Miliaria, White blood cell count increased
Clinical narrative: My skin is heating up a lot; This is a spontaneous report from a contactable consumer.  A 31-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) lot number EL3302 via an unspecified route of administration on 22Jan2021 at SINGLE DOSE for covid-19 immunisation.  Medical history included Hashimoto's disease. Concomitant medication included levothyroxine (LEVOTHYROXINE). Ten minutes after vaccination the patient reported anaphylactic reaction to it "my skin is heating up a lot" and was hospitalized on the same day 22Jan2021. the consumer was discharged same day 6 hours later. The patient underwent lab tests and procedures which included investigation: everything was normal. The action taken was not applicable. Therapeutic measures included "Benadryl, and they gave me Epipen and then I am taking Benadryl.  The patient just wanted to knowhow many days or how long does it take for the first vaccine to be out of your system, or how long will I be getting these reactions. Patient worked in a retirement facility. Event outcome is unknown.
Age: 31.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Anaphylactic reaction, Laboratory test normal, Skin warm
Clinical narrative: My skin is heating up a lot; This is a spontaneous report from a contactable consumer.  A 31-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) lot number EL3302 via an unspecified route of administration on 22Jan2021 at SINGLE DOSE for covid-19 immunisation.  Medical history included Hashimoto's disease. Concomitant medication included levothyroxine (LEVOTHYROXINE). Ten minutes after vaccination the patient reported anaphylactic reaction to it "my skin is heating up a lot" and was hospitalized on the same day 22Jan2021. the consumer was discharged same day 6 hours later. The patient underwent lab tests and procedures which included investigation: everything was normal. The action taken was not applicable. Therapeutic measures included "Benadryl, and they gave me Epipen and then I am taking Benadryl.  The patient just wanted to knowhow many days or how long does it take for the first vaccine to be out of your system, or how long will I be getting these reactions. Patient worked in a retirement facility. Event outcome is unknown.
Age: 90.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Bacterial test positive, Blood bilirubin increased, Blood creatinine increased, Blood glucose normal, Blood potassium decreased
Clinical narrative: ON 12/31/20, RES RECEIVED FIRST IN SERIES MODERNA COVID VACCINE. ON 01/05/21 AT 15:45, RESIDENT NOTED TO HAVE FALLEN BY SLIDING FORWARD OUT OF W/C CAUSING L HAND SKIN TEAR AND L EYE DARK PURPLE BRUISE. ON 01/05/21 AT 12:09 RESIDENT WAS NOTED TO HAVE TESTED POSITIVE FOR COVID, AND TO BE SENT TO HOSPITAL FOR BAM INFUSION. OOF AT 16:38, RTF COVID UNIT AT 20:00 OF 01/05.  ON 01/06 AT 00:37, NEUROLOGICAL CHECK (R/T TO S/P FALL), NOTED TO BE WNL. ON 01/07/21 AT 05:13, RESIDENT NOTED TO HAVE NEW ONSET OF INABILITY TO SWALLOW CRUSHED MEDS, NEW ONSET OF DIFFICULTY SUCKING THROUGH STRAW, DECREASED COMMUNICATION WITH STAFF, AND SHIVERING WITH TEMP OF 97.5. ON 01/07/21 AT 15:23, NOTATION AGAIN OF DARK PURPLE BRUISE TO L EYE AND NO FURTHER INJURY R/T FALL. AT 17:06 RES NOTED TO HAVE INCREASED FATIGUE, DECREASED APPETITE AND INCREASE IN PAIN. LABS DONE (CBC, CMP). APRN REVIEWED LABS AND ORDERED IV NS X 1 L AT 80 ML/HOUR. ON 01/08 AT 11:21 NOTED RES CONTINUES WITH "COVID SYMPTOMS" VERY RESTLESS, SHAKING, AROUSABLE TO VERBAL STIMULI BUT NON-VERBAL IN INTERACTION, HR AT 119, BP AT 136/82, RR 34, EVEN AND RAPID RHYTHM. BMP HAD BEEN REPEATED PRIOR TO 11:21 AND NOTED THAT APRN ORDERED HER TO BE ADMITTED TO HOSPITAL WITH CRITICAL SERUM SODIUM LEVEL OF 162 AND WAS SENT OUT WITH EMS AT 11:21. BY 16:38 WAS ADMITTED TO OCH WITH COVID-19 DIAGNOSIS.
Age: 90.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Blood sodium increased, Blood urea increased, Chest X-ray normal, Computerised tomogram head abnormal, Computerised tomogram thorax normal
Clinical narrative: ON 12/31/20, RES RECEIVED FIRST IN SERIES MODERNA COVID VACCINE. ON 01/05/21 AT 15:45, RESIDENT NOTED TO HAVE FALLEN BY SLIDING FORWARD OUT OF W/C CAUSING L HAND SKIN TEAR AND L EYE DARK PURPLE BRUISE. ON 01/05/21 AT 12:09 RESIDENT WAS NOTED TO HAVE TESTED POSITIVE FOR COVID, AND TO BE SENT TO HOSPITAL FOR BAM INFUSION. OOF AT 16:38, RTF COVID UNIT AT 20:00 OF 01/05.  ON 01/06 AT 00:37, NEUROLOGICAL CHECK (R/T TO S/P FALL), NOTED TO BE WNL. ON 01/07/21 AT 05:13, RESIDENT NOTED TO HAVE NEW ONSET OF INABILITY TO SWALLOW CRUSHED MEDS, NEW ONSET OF DIFFICULTY SUCKING THROUGH STRAW, DECREASED COMMUNICATION WITH STAFF, AND SHIVERING WITH TEMP OF 97.5. ON 01/07/21 AT 15:23, NOTATION AGAIN OF DARK PURPLE BRUISE TO L EYE AND NO FURTHER INJURY R/T FALL. AT 17:06 RES NOTED TO HAVE INCREASED FATIGUE, DECREASED APPETITE AND INCREASE IN PAIN. LABS DONE (CBC, CMP). APRN REVIEWED LABS AND ORDERED IV NS X 1 L AT 80 ML/HOUR. ON 01/08 AT 11:21 NOTED RES CONTINUES WITH "COVID SYMPTOMS" VERY RESTLESS, SHAKING, AROUSABLE TO VERBAL STIMULI BUT NON-VERBAL IN INTERACTION, HR AT 119, BP AT 136/82, RR 34, EVEN AND RAPID RHYTHM. BMP HAD BEEN REPEATED PRIOR TO 11:21 AND NOTED THAT APRN ORDERED HER TO BE ADMITTED TO HOSPITAL WITH CRITICAL SERUM SODIUM LEVEL OF 162 AND WAS SENT OUT WITH EMS AT 11:21. BY 16:38 WAS ADMITTED TO OCH WITH COVID-19 DIAGNOSIS.
Age: 90.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Coronavirus infection, Culture urine negative, Death, Decreased appetite, Fluid intake reduced
Clinical narrative: ON 12/31/20, RES RECEIVED FIRST IN SERIES MODERNA COVID VACCINE. ON 01/05/21 AT 15:45, RESIDENT NOTED TO HAVE FALLEN BY SLIDING FORWARD OUT OF W/C CAUSING L HAND SKIN TEAR AND L EYE DARK PURPLE BRUISE. ON 01/05/21 AT 12:09 RESIDENT WAS NOTED TO HAVE TESTED POSITIVE FOR COVID, AND TO BE SENT TO HOSPITAL FOR BAM INFUSION. OOF AT 16:38, RTF COVID UNIT AT 20:00 OF 01/05.  ON 01/06 AT 00:37, NEUROLOGICAL CHECK (R/T TO S/P FALL), NOTED TO BE WNL. ON 01/07/21 AT 05:13, RESIDENT NOTED TO HAVE NEW ONSET OF INABILITY TO SWALLOW CRUSHED MEDS, NEW ONSET OF DIFFICULTY SUCKING THROUGH STRAW, DECREASED COMMUNICATION WITH STAFF, AND SHIVERING WITH TEMP OF 97.5. ON 01/07/21 AT 15:23, NOTATION AGAIN OF DARK PURPLE BRUISE TO L EYE AND NO FURTHER INJURY R/T FALL. AT 17:06 RES NOTED TO HAVE INCREASED FATIGUE, DECREASED APPETITE AND INCREASE IN PAIN. LABS DONE (CBC, CMP). APRN REVIEWED LABS AND ORDERED IV NS X 1 L AT 80 ML/HOUR. ON 01/08 AT 11:21 NOTED RES CONTINUES WITH "COVID SYMPTOMS" VERY RESTLESS, SHAKING, AROUSABLE TO VERBAL STIMULI BUT NON-VERBAL IN INTERACTION, HR AT 119, BP AT 136/82, RR 34, EVEN AND RAPID RHYTHM. BMP HAD BEEN REPEATED PRIOR TO 11:21 AND NOTED THAT APRN ORDERED HER TO BE ADMITTED TO HOSPITAL WITH CRITICAL SERUM SODIUM LEVEL OF 162 AND WAS SENT OUT WITH EMS AT 11:21. BY 16:38 WAS ADMITTED TO OCH WITH COVID-19 DIAGNOSIS.
Age: 90.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: General physical health deterioration, Haematoma, Haemoglobin decreased, Hyporesponsive to stimuli, Nitrite urine absent
Clinical narrative: ON 12/31/20, RES RECEIVED FIRST IN SERIES MODERNA COVID VACCINE. ON 01/05/21 AT 15:45, RESIDENT NOTED TO HAVE FALLEN BY SLIDING FORWARD OUT OF W/C CAUSING L HAND SKIN TEAR AND L EYE DARK PURPLE BRUISE. ON 01/05/21 AT 12:09 RESIDENT WAS NOTED TO HAVE TESTED POSITIVE FOR COVID, AND TO BE SENT TO HOSPITAL FOR BAM INFUSION. OOF AT 16:38, RTF COVID UNIT AT 20:00 OF 01/05.  ON 01/06 AT 00:37, NEUROLOGICAL CHECK (R/T TO S/P FALL), NOTED TO BE WNL. ON 01/07/21 AT 05:13, RESIDENT NOTED TO HAVE NEW ONSET OF INABILITY TO SWALLOW CRUSHED MEDS, NEW ONSET OF DIFFICULTY SUCKING THROUGH STRAW, DECREASED COMMUNICATION WITH STAFF, AND SHIVERING WITH TEMP OF 97.5. ON 01/07/21 AT 15:23, NOTATION AGAIN OF DARK PURPLE BRUISE TO L EYE AND NO FURTHER INJURY R/T FALL. AT 17:06 RES NOTED TO HAVE INCREASED FATIGUE, DECREASED APPETITE AND INCREASE IN PAIN. LABS DONE (CBC, CMP). APRN REVIEWED LABS AND ORDERED IV NS X 1 L AT 80 ML/HOUR. ON 01/08 AT 11:21 NOTED RES CONTINUES WITH "COVID SYMPTOMS" VERY RESTLESS, SHAKING, AROUSABLE TO VERBAL STIMULI BUT NON-VERBAL IN INTERACTION, HR AT 119, BP AT 136/82, RR 34, EVEN AND RAPID RHYTHM. BMP HAD BEEN REPEATED PRIOR TO 11:21 AND NOTED THAT APRN ORDERED HER TO BE ADMITTED TO HOSPITAL WITH CRITICAL SERUM SODIUM LEVEL OF 162 AND WAS SENT OUT WITH EMS AT 11:21. BY 16:38 WAS ADMITTED TO OCH WITH COVID-19 DIAGNOSIS.
Age: 90.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Platelet count normal, SARS-CoV-2 test positive, White blood cell count increased, White blood cells urine positive
Clinical narrative: ON 12/31/20, RES RECEIVED FIRST IN SERIES MODERNA COVID VACCINE. ON 01/05/21 AT 15:45, RESIDENT NOTED TO HAVE FALLEN BY SLIDING FORWARD OUT OF W/C CAUSING L HAND SKIN TEAR AND L EYE DARK PURPLE BRUISE. ON 01/05/21 AT 12:09 RESIDENT WAS NOTED TO HAVE TESTED POSITIVE FOR COVID, AND TO BE SENT TO HOSPITAL FOR BAM INFUSION. OOF AT 16:38, RTF COVID UNIT AT 20:00 OF 01/05.  ON 01/06 AT 00:37, NEUROLOGICAL CHECK (R/T TO S/P FALL), NOTED TO BE WNL. ON 01/07/21 AT 05:13, RESIDENT NOTED TO HAVE NEW ONSET OF INABILITY TO SWALLOW CRUSHED MEDS, NEW ONSET OF DIFFICULTY SUCKING THROUGH STRAW, DECREASED COMMUNICATION WITH STAFF, AND SHIVERING WITH TEMP OF 97.5. ON 01/07/21 AT 15:23, NOTATION AGAIN OF DARK PURPLE BRUISE TO L EYE AND NO FURTHER INJURY R/T FALL. AT 17:06 RES NOTED TO HAVE INCREASED FATIGUE, DECREASED APPETITE AND INCREASE IN PAIN. LABS DONE (CBC, CMP). APRN REVIEWED LABS AND ORDERED IV NS X 1 L AT 80 ML/HOUR. ON 01/08 AT 11:21 NOTED RES CONTINUES WITH "COVID SYMPTOMS" VERY RESTLESS, SHAKING, AROUSABLE TO VERBAL STIMULI BUT NON-VERBAL IN INTERACTION, HR AT 119, BP AT 136/82, RR 34, EVEN AND RAPID RHYTHM. BMP HAD BEEN REPEATED PRIOR TO 11:21 AND NOTED THAT APRN ORDERED HER TO BE ADMITTED TO HOSPITAL WITH CRITICAL SERUM SODIUM LEVEL OF 162 AND WAS SENT OUT WITH EMS AT 11:21. BY 16:38 WAS ADMITTED TO OCH WITH COVID-19 DIAGNOSIS.
Age: 90.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Anion gap, Anion gap normal, Anisocytosis, Blood bicarbonate normal, Blood bilirubin normal
Clinical narrative: ON 12/31/20, RES RECEIVED FIRST IN SERIES MODERNA COVID VACCINE. ON 01/05/21 AT 15:45, RESIDENT NOTED TO HAVE FALLEN BY SLIDING FORWARD OUT OF W/C CAUSING L HAND SKIN TEAR AND L EYE DARK PURPLE BRUISE. ON 01/05/21 AT 12:09 RESIDENT WAS NOTED TO HAVE TESTED POSITIVE FOR COVID, AND TO BE SENT TO HOSPITAL FOR BAM INFUSION. OOF AT 16:38, RTF COVID UNIT AT 20:00 OF 01/05.  ON 01/06 AT 00:37, NEUROLOGICAL CHECK (R/T TO S/P FALL), NOTED TO BE WNL. ON 01/07/21 AT 05:13, RESIDENT NOTED TO HAVE NEW ONSET OF INABILITY TO SWALLOW CRUSHED MEDS, NEW ONSET OF DIFFICULTY SUCKING THROUGH STRAW, DECREASED COMMUNICATION WITH STAFF, AND SHIVERING WITH TEMP OF 97.5. ON 01/07/21 AT 15:23, NOTATION AGAIN OF DARK PURPLE BRUISE TO L EYE AND NO FURTHER INJURY R/T FALL. AT 17:06 RES NOTED TO HAVE INCREASED FATIGUE, DECREASED APPETITE AND INCREASE IN PAIN. LABS DONE (CBC, CMP). APRN REVIEWED LABS AND ORDERED IV NS X 1 L AT 80 ML/HOUR. ON 01/08 AT 11:21 NOTED RES CONTINUES WITH "COVID SYMPTOMS" VERY RESTLESS, SHAKING, AROUSABLE TO VERBAL STIMULI BUT NON-VERBAL IN INTERACTION, HR AT 119, BP AT 136/82, RR 34, EVEN AND RAPID RHYTHM. BMP HAD BEEN REPEATED PRIOR TO 11:21 AND NOTED THAT APRN ORDERED HER TO BE ADMITTED TO HOSPITAL WITH CRITICAL SERUM SODIUM LEVEL OF 162 AND WAS SENT OUT WITH EMS AT 11:21. BY 16:38 WAS ADMITTED TO OCH WITH COVID-19 DIAGNOSIS.
Age: 90.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Blood calcium decreased, Blood chloride increased, Blood creatinine normal, Blood glucose increased, Blood immunoglobulin G decreased
Clinical narrative: ON 12/31/20, RES RECEIVED FIRST IN SERIES MODERNA COVID VACCINE. ON 01/05/21 AT 15:45, RESIDENT NOTED TO HAVE FALLEN BY SLIDING FORWARD OUT OF W/C CAUSING L HAND SKIN TEAR AND L EYE DARK PURPLE BRUISE. ON 01/05/21 AT 12:09 RESIDENT WAS NOTED TO HAVE TESTED POSITIVE FOR COVID, AND TO BE SENT TO HOSPITAL FOR BAM INFUSION. OOF AT 16:38, RTF COVID UNIT AT 20:00 OF 01/05.  ON 01/06 AT 00:37, NEUROLOGICAL CHECK (R/T TO S/P FALL), NOTED TO BE WNL. ON 01/07/21 AT 05:13, RESIDENT NOTED TO HAVE NEW ONSET OF INABILITY TO SWALLOW CRUSHED MEDS, NEW ONSET OF DIFFICULTY SUCKING THROUGH STRAW, DECREASED COMMUNICATION WITH STAFF, AND SHIVERING WITH TEMP OF 97.5. ON 01/07/21 AT 15:23, NOTATION AGAIN OF DARK PURPLE BRUISE TO L EYE AND NO FURTHER INJURY R/T FALL. AT 17:06 RES NOTED TO HAVE INCREASED FATIGUE, DECREASED APPETITE AND INCREASE IN PAIN. LABS DONE (CBC, CMP). APRN REVIEWED LABS AND ORDERED IV NS X 1 L AT 80 ML/HOUR. ON 01/08 AT 11:21 NOTED RES CONTINUES WITH "COVID SYMPTOMS" VERY RESTLESS, SHAKING, AROUSABLE TO VERBAL STIMULI BUT NON-VERBAL IN INTERACTION, HR AT 119, BP AT 136/82, RR 34, EVEN AND RAPID RHYTHM. BMP HAD BEEN REPEATED PRIOR TO 11:21 AND NOTED THAT APRN ORDERED HER TO BE ADMITTED TO HOSPITAL WITH CRITICAL SERUM SODIUM LEVEL OF 162 AND WAS SENT OUT WITH EMS AT 11:21. BY 16:38 WAS ADMITTED TO OCH WITH COVID-19 DIAGNOSIS.
Age: 90.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Blood immunoglobulin G normal, Blood potassium normal, Blood sodium increased, Blood urea increased, Blood urea nitrogen/creatinine ratio increased
Clinical narrative: ON 12/31/20, RES RECEIVED FIRST IN SERIES MODERNA COVID VACCINE. ON 01/05/21 AT 15:45, RESIDENT NOTED TO HAVE FALLEN BY SLIDING FORWARD OUT OF W/C CAUSING L HAND SKIN TEAR AND L EYE DARK PURPLE BRUISE. ON 01/05/21 AT 12:09 RESIDENT WAS NOTED TO HAVE TESTED POSITIVE FOR COVID, AND TO BE SENT TO HOSPITAL FOR BAM INFUSION. OOF AT 16:38, RTF COVID UNIT AT 20:00 OF 01/05.  ON 01/06 AT 00:37, NEUROLOGICAL CHECK (R/T TO S/P FALL), NOTED TO BE WNL. ON 01/07/21 AT 05:13, RESIDENT NOTED TO HAVE NEW ONSET OF INABILITY TO SWALLOW CRUSHED MEDS, NEW ONSET OF DIFFICULTY SUCKING THROUGH STRAW, DECREASED COMMUNICATION WITH STAFF, AND SHIVERING WITH TEMP OF 97.5. ON 01/07/21 AT 15:23, NOTATION AGAIN OF DARK PURPLE BRUISE TO L EYE AND NO FURTHER INJURY R/T FALL. AT 17:06 RES NOTED TO HAVE INCREASED FATIGUE, DECREASED APPETITE AND INCREASE IN PAIN. LABS DONE (CBC, CMP). APRN REVIEWED LABS AND ORDERED IV NS X 1 L AT 80 ML/HOUR. ON 01/08 AT 11:21 NOTED RES CONTINUES WITH "COVID SYMPTOMS" VERY RESTLESS, SHAKING, AROUSABLE TO VERBAL STIMULI BUT NON-VERBAL IN INTERACTION, HR AT 119, BP AT 136/82, RR 34, EVEN AND RAPID RHYTHM. BMP HAD BEEN REPEATED PRIOR TO 11:21 AND NOTED THAT APRN ORDERED HER TO BE ADMITTED TO HOSPITAL WITH CRITICAL SERUM SODIUM LEVEL OF 162 AND WAS SENT OUT WITH EMS AT 11:21. BY 16:38 WAS ADMITTED TO OCH WITH COVID-19 DIAGNOSIS.
Age: 90.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Blood urea normal, Body temperature decreased, COVID-19, Carbon dioxide normal, Chills
Clinical narrative: ON 12/31/20, RES RECEIVED FIRST IN SERIES MODERNA COVID VACCINE. ON 01/05/21 AT 15:45, RESIDENT NOTED TO HAVE FALLEN BY SLIDING FORWARD OUT OF W/C CAUSING L HAND SKIN TEAR AND L EYE DARK PURPLE BRUISE. ON 01/05/21 AT 12:09 RESIDENT WAS NOTED TO HAVE TESTED POSITIVE FOR COVID, AND TO BE SENT TO HOSPITAL FOR BAM INFUSION. OOF AT 16:38, RTF COVID UNIT AT 20:00 OF 01/05.  ON 01/06 AT 00:37, NEUROLOGICAL CHECK (R/T TO S/P FALL), NOTED TO BE WNL. ON 01/07/21 AT 05:13, RESIDENT NOTED TO HAVE NEW ONSET OF INABILITY TO SWALLOW CRUSHED MEDS, NEW ONSET OF DIFFICULTY SUCKING THROUGH STRAW, DECREASED COMMUNICATION WITH STAFF, AND SHIVERING WITH TEMP OF 97.5. ON 01/07/21 AT 15:23, NOTATION AGAIN OF DARK PURPLE BRUISE TO L EYE AND NO FURTHER INJURY R/T FALL. AT 17:06 RES NOTED TO HAVE INCREASED FATIGUE, DECREASED APPETITE AND INCREASE IN PAIN. LABS DONE (CBC, CMP). APRN REVIEWED LABS AND ORDERED IV NS X 1 L AT 80 ML/HOUR. ON 01/08 AT 11:21 NOTED RES CONTINUES WITH "COVID SYMPTOMS" VERY RESTLESS, SHAKING, AROUSABLE TO VERBAL STIMULI BUT NON-VERBAL IN INTERACTION, HR AT 119, BP AT 136/82, RR 34, EVEN AND RAPID RHYTHM. BMP HAD BEEN REPEATED PRIOR TO 11:21 AND NOTED THAT APRN ORDERED HER TO BE ADMITTED TO HOSPITAL WITH CRITICAL SERUM SODIUM LEVEL OF 162 AND WAS SENT OUT WITH EMS AT 11:21. BY 16:38 WAS ADMITTED TO OCH WITH COVID-19 DIAGNOSIS.
Age: 90.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Communication disorder, Decreased appetite, Depressed level of consciousness, Dysphagia, Eye contusion
Clinical narrative: ON 12/31/20, RES RECEIVED FIRST IN SERIES MODERNA COVID VACCINE. ON 01/05/21 AT 15:45, RESIDENT NOTED TO HAVE FALLEN BY SLIDING FORWARD OUT OF W/C CAUSING L HAND SKIN TEAR AND L EYE DARK PURPLE BRUISE. ON 01/05/21 AT 12:09 RESIDENT WAS NOTED TO HAVE TESTED POSITIVE FOR COVID, AND TO BE SENT TO HOSPITAL FOR BAM INFUSION. OOF AT 16:38, RTF COVID UNIT AT 20:00 OF 01/05.  ON 01/06 AT 00:37, NEUROLOGICAL CHECK (R/T TO S/P FALL), NOTED TO BE WNL. ON 01/07/21 AT 05:13, RESIDENT NOTED TO HAVE NEW ONSET OF INABILITY TO SWALLOW CRUSHED MEDS, NEW ONSET OF DIFFICULTY SUCKING THROUGH STRAW, DECREASED COMMUNICATION WITH STAFF, AND SHIVERING WITH TEMP OF 97.5. ON 01/07/21 AT 15:23, NOTATION AGAIN OF DARK PURPLE BRUISE TO L EYE AND NO FURTHER INJURY R/T FALL. AT 17:06 RES NOTED TO HAVE INCREASED FATIGUE, DECREASED APPETITE AND INCREASE IN PAIN. LABS DONE (CBC, CMP). APRN REVIEWED LABS AND ORDERED IV NS X 1 L AT 80 ML/HOUR. ON 01/08 AT 11:21 NOTED RES CONTINUES WITH "COVID SYMPTOMS" VERY RESTLESS, SHAKING, AROUSABLE TO VERBAL STIMULI BUT NON-VERBAL IN INTERACTION, HR AT 119, BP AT 136/82, RR 34, EVEN AND RAPID RHYTHM. BMP HAD BEEN REPEATED PRIOR TO 11:21 AND NOTED THAT APRN ORDERED HER TO BE ADMITTED TO HOSPITAL WITH CRITICAL SERUM SODIUM LEVEL OF 162 AND WAS SENT OUT WITH EMS AT 11:21. BY 16:38 WAS ADMITTED TO OCH WITH COVID-19 DIAGNOSIS.
Age: 90.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Fall, Fatigue, Full blood count, Glomerular filtration rate decreased, Haematocrit normal
Clinical narrative: ON 12/31/20, RES RECEIVED FIRST IN SERIES MODERNA COVID VACCINE. ON 01/05/21 AT 15:45, RESIDENT NOTED TO HAVE FALLEN BY SLIDING FORWARD OUT OF W/C CAUSING L HAND SKIN TEAR AND L EYE DARK PURPLE BRUISE. ON 01/05/21 AT 12:09 RESIDENT WAS NOTED TO HAVE TESTED POSITIVE FOR COVID, AND TO BE SENT TO HOSPITAL FOR BAM INFUSION. OOF AT 16:38, RTF COVID UNIT AT 20:00 OF 01/05.  ON 01/06 AT 00:37, NEUROLOGICAL CHECK (R/T TO S/P FALL), NOTED TO BE WNL. ON 01/07/21 AT 05:13, RESIDENT NOTED TO HAVE NEW ONSET OF INABILITY TO SWALLOW CRUSHED MEDS, NEW ONSET OF DIFFICULTY SUCKING THROUGH STRAW, DECREASED COMMUNICATION WITH STAFF, AND SHIVERING WITH TEMP OF 97.5. ON 01/07/21 AT 15:23, NOTATION AGAIN OF DARK PURPLE BRUISE TO L EYE AND NO FURTHER INJURY R/T FALL. AT 17:06 RES NOTED TO HAVE INCREASED FATIGUE, DECREASED APPETITE AND INCREASE IN PAIN. LABS DONE (CBC, CMP). APRN REVIEWED LABS AND ORDERED IV NS X 1 L AT 80 ML/HOUR. ON 01/08 AT 11:21 NOTED RES CONTINUES WITH "COVID SYMPTOMS" VERY RESTLESS, SHAKING, AROUSABLE TO VERBAL STIMULI BUT NON-VERBAL IN INTERACTION, HR AT 119, BP AT 136/82, RR 34, EVEN AND RAPID RHYTHM. BMP HAD BEEN REPEATED PRIOR TO 11:21 AND NOTED THAT APRN ORDERED HER TO BE ADMITTED TO HOSPITAL WITH CRITICAL SERUM SODIUM LEVEL OF 162 AND WAS SENT OUT WITH EMS AT 11:21. BY 16:38 WAS ADMITTED TO OCH WITH COVID-19 DIAGNOSIS.
Age: 90.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Haemoglobin normal, Hepatic enzyme, Liver function test normal, Lymphopenia, Mean cell haemoglobin
Clinical narrative: ON 12/31/20, RES RECEIVED FIRST IN SERIES MODERNA COVID VACCINE. ON 01/05/21 AT 15:45, RESIDENT NOTED TO HAVE FALLEN BY SLIDING FORWARD OUT OF W/C CAUSING L HAND SKIN TEAR AND L EYE DARK PURPLE BRUISE. ON 01/05/21 AT 12:09 RESIDENT WAS NOTED TO HAVE TESTED POSITIVE FOR COVID, AND TO BE SENT TO HOSPITAL FOR BAM INFUSION. OOF AT 16:38, RTF COVID UNIT AT 20:00 OF 01/05.  ON 01/06 AT 00:37, NEUROLOGICAL CHECK (R/T TO S/P FALL), NOTED TO BE WNL. ON 01/07/21 AT 05:13, RESIDENT NOTED TO HAVE NEW ONSET OF INABILITY TO SWALLOW CRUSHED MEDS, NEW ONSET OF DIFFICULTY SUCKING THROUGH STRAW, DECREASED COMMUNICATION WITH STAFF, AND SHIVERING WITH TEMP OF 97.5. ON 01/07/21 AT 15:23, NOTATION AGAIN OF DARK PURPLE BRUISE TO L EYE AND NO FURTHER INJURY R/T FALL. AT 17:06 RES NOTED TO HAVE INCREASED FATIGUE, DECREASED APPETITE AND INCREASE IN PAIN. LABS DONE (CBC, CMP). APRN REVIEWED LABS AND ORDERED IV NS X 1 L AT 80 ML/HOUR. ON 01/08 AT 11:21 NOTED RES CONTINUES WITH "COVID SYMPTOMS" VERY RESTLESS, SHAKING, AROUSABLE TO VERBAL STIMULI BUT NON-VERBAL IN INTERACTION, HR AT 119, BP AT 136/82, RR 34, EVEN AND RAPID RHYTHM. BMP HAD BEEN REPEATED PRIOR TO 11:21 AND NOTED THAT APRN ORDERED HER TO BE ADMITTED TO HOSPITAL WITH CRITICAL SERUM SODIUM LEVEL OF 162 AND WAS SENT OUT WITH EMS AT 11:21. BY 16:38 WAS ADMITTED TO OCH WITH COVID-19 DIAGNOSIS.
Age: 90.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Mean cell haemoglobin increased, Mean cell volume increased, Metabolic function test, Pain, Platelet count normal
Clinical narrative: ON 12/31/20, RES RECEIVED FIRST IN SERIES MODERNA COVID VACCINE. ON 01/05/21 AT 15:45, RESIDENT NOTED TO HAVE FALLEN BY SLIDING FORWARD OUT OF W/C CAUSING L HAND SKIN TEAR AND L EYE DARK PURPLE BRUISE. ON 01/05/21 AT 12:09 RESIDENT WAS NOTED TO HAVE TESTED POSITIVE FOR COVID, AND TO BE SENT TO HOSPITAL FOR BAM INFUSION. OOF AT 16:38, RTF COVID UNIT AT 20:00 OF 01/05.  ON 01/06 AT 00:37, NEUROLOGICAL CHECK (R/T TO S/P FALL), NOTED TO BE WNL. ON 01/07/21 AT 05:13, RESIDENT NOTED TO HAVE NEW ONSET OF INABILITY TO SWALLOW CRUSHED MEDS, NEW ONSET OF DIFFICULTY SUCKING THROUGH STRAW, DECREASED COMMUNICATION WITH STAFF, AND SHIVERING WITH TEMP OF 97.5. ON 01/07/21 AT 15:23, NOTATION AGAIN OF DARK PURPLE BRUISE TO L EYE AND NO FURTHER INJURY R/T FALL. AT 17:06 RES NOTED TO HAVE INCREASED FATIGUE, DECREASED APPETITE AND INCREASE IN PAIN. LABS DONE (CBC, CMP). APRN REVIEWED LABS AND ORDERED IV NS X 1 L AT 80 ML/HOUR. ON 01/08 AT 11:21 NOTED RES CONTINUES WITH "COVID SYMPTOMS" VERY RESTLESS, SHAKING, AROUSABLE TO VERBAL STIMULI BUT NON-VERBAL IN INTERACTION, HR AT 119, BP AT 136/82, RR 34, EVEN AND RAPID RHYTHM. BMP HAD BEEN REPEATED PRIOR TO 11:21 AND NOTED THAT APRN ORDERED HER TO BE ADMITTED TO HOSPITAL WITH CRITICAL SERUM SODIUM LEVEL OF 162 AND WAS SENT OUT WITH EMS AT 11:21. BY 16:38 WAS ADMITTED TO OCH WITH COVID-19 DIAGNOSIS.
Age: 90.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Poor sucking reflex, Protein total, Protein total normal, Red blood cell anisocytes present, Red blood cell count decreased
Clinical narrative: ON 12/31/20, RES RECEIVED FIRST IN SERIES MODERNA COVID VACCINE. ON 01/05/21 AT 15:45, RESIDENT NOTED TO HAVE FALLEN BY SLIDING FORWARD OUT OF W/C CAUSING L HAND SKIN TEAR AND L EYE DARK PURPLE BRUISE. ON 01/05/21 AT 12:09 RESIDENT WAS NOTED TO HAVE TESTED POSITIVE FOR COVID, AND TO BE SENT TO HOSPITAL FOR BAM INFUSION. OOF AT 16:38, RTF COVID UNIT AT 20:00 OF 01/05.  ON 01/06 AT 00:37, NEUROLOGICAL CHECK (R/T TO S/P FALL), NOTED TO BE WNL. ON 01/07/21 AT 05:13, RESIDENT NOTED TO HAVE NEW ONSET OF INABILITY TO SWALLOW CRUSHED MEDS, NEW ONSET OF DIFFICULTY SUCKING THROUGH STRAW, DECREASED COMMUNICATION WITH STAFF, AND SHIVERING WITH TEMP OF 97.5. ON 01/07/21 AT 15:23, NOTATION AGAIN OF DARK PURPLE BRUISE TO L EYE AND NO FURTHER INJURY R/T FALL. AT 17:06 RES NOTED TO HAVE INCREASED FATIGUE, DECREASED APPETITE AND INCREASE IN PAIN. LABS DONE (CBC, CMP). APRN REVIEWED LABS AND ORDERED IV NS X 1 L AT 80 ML/HOUR. ON 01/08 AT 11:21 NOTED RES CONTINUES WITH "COVID SYMPTOMS" VERY RESTLESS, SHAKING, AROUSABLE TO VERBAL STIMULI BUT NON-VERBAL IN INTERACTION, HR AT 119, BP AT 136/82, RR 34, EVEN AND RAPID RHYTHM. BMP HAD BEEN REPEATED PRIOR TO 11:21 AND NOTED THAT APRN ORDERED HER TO BE ADMITTED TO HOSPITAL WITH CRITICAL SERUM SODIUM LEVEL OF 162 AND WAS SENT OUT WITH EMS AT 11:21. BY 16:38 WAS ADMITTED TO OCH WITH COVID-19 DIAGNOSIS.
Age: 90.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Red cell distribution width increased, Reflexes abnormal, Restlessness, SARS-CoV-2 test positive, Skin laceration
Clinical narrative: ON 12/31/20, RES RECEIVED FIRST IN SERIES MODERNA COVID VACCINE. ON 01/05/21 AT 15:45, RESIDENT NOTED TO HAVE FALLEN BY SLIDING FORWARD OUT OF W/C CAUSING L HAND SKIN TEAR AND L EYE DARK PURPLE BRUISE. ON 01/05/21 AT 12:09 RESIDENT WAS NOTED TO HAVE TESTED POSITIVE FOR COVID, AND TO BE SENT TO HOSPITAL FOR BAM INFUSION. OOF AT 16:38, RTF COVID UNIT AT 20:00 OF 01/05.  ON 01/06 AT 00:37, NEUROLOGICAL CHECK (R/T TO S/P FALL), NOTED TO BE WNL. ON 01/07/21 AT 05:13, RESIDENT NOTED TO HAVE NEW ONSET OF INABILITY TO SWALLOW CRUSHED MEDS, NEW ONSET OF DIFFICULTY SUCKING THROUGH STRAW, DECREASED COMMUNICATION WITH STAFF, AND SHIVERING WITH TEMP OF 97.5. ON 01/07/21 AT 15:23, NOTATION AGAIN OF DARK PURPLE BRUISE TO L EYE AND NO FURTHER INJURY R/T FALL. AT 17:06 RES NOTED TO HAVE INCREASED FATIGUE, DECREASED APPETITE AND INCREASE IN PAIN. LABS DONE (CBC, CMP). APRN REVIEWED LABS AND ORDERED IV NS X 1 L AT 80 ML/HOUR. ON 01/08 AT 11:21 NOTED RES CONTINUES WITH "COVID SYMPTOMS" VERY RESTLESS, SHAKING, AROUSABLE TO VERBAL STIMULI BUT NON-VERBAL IN INTERACTION, HR AT 119, BP AT 136/82, RR 34, EVEN AND RAPID RHYTHM. BMP HAD BEEN REPEATED PRIOR TO 11:21 AND NOTED THAT APRN ORDERED HER TO BE ADMITTED TO HOSPITAL WITH CRITICAL SERUM SODIUM LEVEL OF 162 AND WAS SENT OUT WITH EMS AT 11:21. BY 16:38 WAS ADMITTED TO OCH WITH COVID-19 DIAGNOSIS.
Age: 90.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Tremor, Wheelchair user, White blood cell count increased
Clinical narrative: ON 12/31/20, RES RECEIVED FIRST IN SERIES MODERNA COVID VACCINE. ON 01/05/21 AT 15:45, RESIDENT NOTED TO HAVE FALLEN BY SLIDING FORWARD OUT OF W/C CAUSING L HAND SKIN TEAR AND L EYE DARK PURPLE BRUISE. ON 01/05/21 AT 12:09 RESIDENT WAS NOTED TO HAVE TESTED POSITIVE FOR COVID, AND TO BE SENT TO HOSPITAL FOR BAM INFUSION. OOF AT 16:38, RTF COVID UNIT AT 20:00 OF 01/05.  ON 01/06 AT 00:37, NEUROLOGICAL CHECK (R/T TO S/P FALL), NOTED TO BE WNL. ON 01/07/21 AT 05:13, RESIDENT NOTED TO HAVE NEW ONSET OF INABILITY TO SWALLOW CRUSHED MEDS, NEW ONSET OF DIFFICULTY SUCKING THROUGH STRAW, DECREASED COMMUNICATION WITH STAFF, AND SHIVERING WITH TEMP OF 97.5. ON 01/07/21 AT 15:23, NOTATION AGAIN OF DARK PURPLE BRUISE TO L EYE AND NO FURTHER INJURY R/T FALL. AT 17:06 RES NOTED TO HAVE INCREASED FATIGUE, DECREASED APPETITE AND INCREASE IN PAIN. LABS DONE (CBC, CMP). APRN REVIEWED LABS AND ORDERED IV NS X 1 L AT 80 ML/HOUR. ON 01/08 AT 11:21 NOTED RES CONTINUES WITH "COVID SYMPTOMS" VERY RESTLESS, SHAKING, AROUSABLE TO VERBAL STIMULI BUT NON-VERBAL IN INTERACTION, HR AT 119, BP AT 136/82, RR 34, EVEN AND RAPID RHYTHM. BMP HAD BEEN REPEATED PRIOR TO 11:21 AND NOTED THAT APRN ORDERED HER TO BE ADMITTED TO HOSPITAL WITH CRITICAL SERUM SODIUM LEVEL OF 162 AND WAS SENT OUT WITH EMS AT 11:21. BY 16:38 WAS ADMITTED TO OCH WITH COVID-19 DIAGNOSIS.
Age: 75.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Abnormal dreams, Erythema, Immediate post-injection reaction, Malaise, Pain in extremity
Clinical narrative: I felt like allergic to something in med; Swoll all up. Hands, arms, feet, extremities; Red face, red arms; Heart pounded hard for about 10 hrs; This is a spontaneous report from a contactable consumer (patient). A 75-year-old female consumer received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on 19Jan2021 16:15 at single dose in left arm for COVID-19 immunization. Medical history included anxiety, colon resection (missing 10-11 inches colon), Gene deficiency for some meds, allergies to some chemicals, sulfa, nitrates, MSG. Concomitant medications included lorazepam (ATIVAN), latanoprost, lifitegrast (XIIDRA) and vitamins. The patient had no other vaccine in four weeks. On 20Jan2021 01:00 AM, the patient had Swoll all up. Hands, arms, feet, extremities. Red face, red arms. Heart Pounded hard for about 10 hrs. Did not start until several hours after the injection. She felt like allergic to something in med. She did not notice swelling in throat.. or breathing issues. Just severe pounding and swollen. Not racing heart, pounding. BP seemed to be okay.. mostly. All events resulted in Doctor or other healthcare professional office/clinic visit. No treatment was received for all events. The patient had no covid prior vaccination and no covid tested post vaccination. The outcome of all events was unknown.  Information about lot/batch number has been requested.
Age: 75.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Palpitations, Peripheral swelling, Sleep disorder
Clinical narrative: I felt like allergic to something in med; Swoll all up. Hands, arms, feet, extremities; Red face, red arms; Heart pounded hard for about 10 hrs; This is a spontaneous report from a contactable consumer (patient). A 75-year-old female consumer received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on 19Jan2021 16:15 at single dose in left arm for COVID-19 immunization. Medical history included anxiety, colon resection (missing 10-11 inches colon), Gene deficiency for some meds, allergies to some chemicals, sulfa, nitrates, MSG. Concomitant medications included lorazepam (ATIVAN), latanoprost, lifitegrast (XIIDRA) and vitamins. The patient had no other vaccine in four weeks. On 20Jan2021 01:00 AM, the patient had Swoll all up. Hands, arms, feet, extremities. Red face, red arms. Heart Pounded hard for about 10 hrs. Did not start until several hours after the injection. She felt like allergic to something in med. She did not notice swelling in throat.. or breathing issues. Just severe pounding and swollen. Not racing heart, pounding. BP seemed to be okay.. mostly. All events resulted in Doctor or other healthcare professional office/clinic visit. No treatment was received for all events. The patient had no covid prior vaccination and no covid tested post vaccination. The outcome of all events was unknown.  Information about lot/batch number has been requested.
Age: 75.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Erythema, Palpitations, Peripheral swelling
Clinical narrative: I felt like allergic to something in med; Swoll all up. Hands, arms, feet, extremities; Red face, red arms; Heart pounded hard for about 10 hrs; This is a spontaneous report from a contactable consumer (patient). A 75-year-old female consumer received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on 19Jan2021 16:15 at single dose in left arm for COVID-19 immunization. Medical history included anxiety, colon resection (missing 10-11 inches colon), Gene deficiency for some meds, allergies to some chemicals, sulfa, nitrates, MSG. Concomitant medications included lorazepam (ATIVAN), latanoprost, lifitegrast (XIIDRA) and vitamins. The patient had no other vaccine in four weeks. On 20Jan2021 01:00 AM, the patient had Swoll all up. Hands, arms, feet, extremities. Red face, red arms. Heart Pounded hard for about 10 hrs. Did not start until several hours after the injection. She felt like allergic to something in med. She did not notice swelling in throat.. or breathing issues. Just severe pounding and swollen. Not racing heart, pounding. BP seemed to be okay.. mostly. All events resulted in Doctor or other healthcare professional office/clinic visit. No treatment was received for all events. The patient had no covid prior vaccination and no covid tested post vaccination. The outcome of all events was unknown.  Information about lot/batch number has been requested.
Age: 29.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dyspnoea, Injection site nodule, Injection site rash, Rash
Clinical narrative: Rash on right side of neck; Rash of bumps on the left arm where injection happened; Rash of bumps on the left arm where injection happened; Some difficulty breathing; This is a spontaneous report from a contactable consumer (patient). A 29-year-old female patient received her first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on left arm on 22Jan2021 13:30 at single dose for COVID-19 immunization. Medical history included asthma, allergies and migraine. Concomitant medication included ibuprofen, albuterol [salbutamol] and sumatriptan. The patient previously took clindamycin and experienced drug allergy. The patient experienced rash of bumps on the left arm where injection happened, rash on right side of neck some difficulty breathing on 22Jan2021 19:30. The patient received treatment Benadryl and albuterol to treat symptoms. The outcome of events was recovered in Jan2021.  Information on the Lot/Batch number has been requested.